课题基金 / 基金详情

Worksite Lifestyle Program for Reducing Diabetes and Cardiovascular Risk in India

Worksite Lifestyle Program for Reducing Diabetes and Cardiovascular Risk in India
印度降低糖尿病和心血管风险的工作场所生活方式计划
批准号:
8964153
负责人:
Kabayam M Venkat Narayan
金额:
$65.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2020-05-31
关键词:
AbsenteeismAdoptionAdultAffectAgeAnthropometryAsian IndianBehaviorBehavior TherapyBlood PressureBody Weight decreasedBusinessesCardiovascular DiseasesCaringChronic DiseaseCommunitiesCommunity WorkersComplications of Diabetes MellitusCountryDataDiabetes MellitusDiabetes preventionDietDropoutEatingEducationEffectivenessEmployeeEnvironmentEpidemicExerciseFamilyFocus GroupsFoodGlucoseGlycosylated hemoglobin AGoalsHealthHealth EducatorsHealth FoodHealth StatusHealth care facilityHealth systemHuman ResourcesIncidenceIndiaIndividualInsuranceInternationalInterventionInterviewInvestmentsLife ExpectancyLife StyleLipidsMaintenanceMeasuresMethodsModelingOutcomeParticipantPharmaceutical PreparationsPhysical activityPlasmaPopulationPopulations at RiskPrediabetes syndromePreventionPrevention programProductivityProgram AcceptabilityProgram EffectivenessQuality of lifeRandomized Controlled TrialsRecommendationReportingResearchResearch PersonnelResourcesRisk FactorsSiteSocial supportSolutionsStrokeStructureTestingTextTimeTrainingTranslationsTriglyceridesWagesWeightWorkWorkplacebaseblood pressure reductioncardiometabolic riskcardiovascular disorder riskcardiovascular risk factorcostcost effectivecost effectivenessdiabetes controldiabetes managementdiabetes riskdisorder preventioneffectiveness measurefasting glucoseglycemic controlgood dietimplementation trialimprovedinnovationintervention programlifestyle interventionlost work timememberpeerpreventprimary outcomeprogramspublic health relevancesatisfactionscale upscreeningsecondary outcomesocialsuccesstrial design

项目摘要

项目成果

Kabayam M Venkat Narayan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Asian Indians have high rates of diabetes, prediabetes and cardio metabolic risk factors. There is strong evidence that lifestyle change, particularly weight loss, increasing physical activity, and improving diet quality can prevent or delay diabetes, reduce cardiometabolic risk factors such as elevated glucose, plasma lipids, and blood pressure, and improve outcomes among individuals with diabetes. Implementing lifestyle change education and support at the worksite may be an effective and cost-effective method to deliver prevention in a way that is acceptable, accessible, and sustainable and overcomes barriers to lifestyle change (e.g., lack of time or resources). Building off previous work by the international study team, this study proposes implementing and evaluating in a pre-post design trial the acceptability, delivery, effectiveness, and cost- effectiveness of a worksite-based lifestyle improvement package including a peer-led lifestyle change education program augmented with changes in the worksite environment that promote social support, healthy eating and exercise. The lifestyle education program will include 2000 adults with prediabetes (HbA1c of 5.7- 6.4%) or unmedicated diabetes (HbA1c = 6.5% identified at screening) across eight diverse worksites in India (changes to the worksite environment will impact a much broader population of employees). A mixed methods approach will be used to evaluate implementation of the program. The study aims to measure: (1) Success of implementation in terms of program adoption (participation and changes in weight and diet and physical activity behaviors among lifestyle class participants); fidelity to the program (activities of study-affiliaed worksite staff; changes to the food options at the worksite canteen; management support for the program; and changes in the worksite environment); and program acceptability as reported by employees, managers, supervisors, and lifestyle education program participants and dropouts during in-depth, semi-structured interviews and focus group discussions. (2) Program effectiveness by evaluating the number of cardiometabolic risk goals reached for reductions in blood pressure, triglycerides, and HbA1c (the primary outcome) and through changes in secondary outcomes including rates of diabetes incidence and regression to normoglycemia and changes in anthropometry, lipids, and fasting glucose. (3) Value and return on the investment of the program for employers by assessing program costs, cost-effectiveness, and changes in staff productivity, absenteeism, health status, and quality of life. This project will deliver scientific innovations (lifestyle education programs with text message supports during maintenance) with social innovations (educated peer health educators delivering a program to a large at risk population) and business innovation (worksite stakeholder commitment and partnering researchers to help deliver the program with fidelity, improve the workplace health environment, and evaluate the model). If the program is shown to be feasible, acceptable, effective, and cost-effective at these worksites, the program could be disseminated to other worksites throughout India and elsewhere.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Environmental Exposures and the Development of Subclinical and Clinical Vascular and Myocardial Disease
  • 批准号:
    10622466
  • 项目类别:
  • 资助金额:
    $10.53万
  • 财政年份:
    2022
  • 负责人:
    Kabayam M Venkat Narayan
  • 依托单位:
An Adaptive Intervention Trial of Home Testing with Behavioral Nudges for Improving COVID-19 Testing and Prevention among People Affected by Diabetes
  • 批准号:
    10447445
  • 项目类别:
  • 资助金额:
    $115.67万
  • 财政年份:
    2022
  • 负责人:
    Kabayam M Venkat Narayan
  • 依托单位:
Environmental Exposures and the Development of Subclinical and Clinical Vascular and Myocardial Disease
  • 批准号:
    10333817
  • 项目类别:
  • 资助金额:
    $14.01万
  • 财政年份:
    2022
  • 负责人:
    Kabayam M Venkat Narayan
  • 依托单位:
An Adaptive Intervention Trial of Home Testing with Behavioral Nudges for Improving COVID-19 Testing and Prevention among People Affected by Diabetes
  • 批准号:
    10548235
  • 项目类别:
  • 资助金额:
    $99.0万
  • 财政年份:
    2022
  • 负责人:
    Kabayam M Venkat Narayan
  • 依托单位:
海外基金